What You Should Know:
- 3Aware, a provider of medical device regulatory compliance solutions, and Mayo Clinic Platform, a collaborative ecosystem for healthcare innovators, today announced a new partnership that will integrate 3Aware's aiSurveillance solution with Mayo Clinic Platform's extensive clinical data resources.
- This collaboration marks a significant milestone in the industry as it will enable medical device manufacturers to automate post-market clinical follow-up (PMCF) and
Read More
Mayo Clinic Health System | News, Analysis, Insights - HIT Consultant
Mayo Clinic and Ayble Health Launch Integrated Care Model for GI Patients
What You Should Know:
- Ayble Health, a digital health platform dedicated to empowering patients with chronic GI conditions, has joined forces with the Mayo Clinic Complex Care Program to create a groundbreaking hybrid care model for digestive health.
- This innovative approach aims to address the unique needs of each patient, providing a combination of virtual and in-person care tailored to their individual acuity level.
Addressing the Silent Epidemic of Digestive Disease
Digestive
Read More
Lucem Health Secures $7.7M for Agnostic AI-Powered Platform
What You Should Know:
Lucem Health, a Mayo Clinic Platform portfolio company, has closed a Series A venture capital funding round of $7.7M led by Mayo Clinic, Granger Management and Mercy (St Louis).Lucem Health helps clinical AI innovators transform data science into innovative, trusted solutions that can detect diseases earlier and optimize care delivery, positively impacting patient lives, improving the physician and provider experience, and ultimately producing improved
Read More
Know Labs/Mayo Clinic Study Proves Noninvasive GM Sensor Accuracy
What You Should Know:
- Know Labs, Inc., an emerging developer of non-invasive medical diagnostic technology, today announced the results of a proof-of-principle study titled, “Detecting Unique Analyte-Specific Radio Frequency Spectral Responses in Liquid Solutions – Implications for Non-Invasive Physiologic Monitoring,” conducted in collaboration with Mayo Clinic.
- The study demonstrates the accuracy of Know Labs’
Read More
Value-Based Administration Enables All VBC Network Stakeholders to Benefit
Despite holding the promise of delivering superior patient outcomes while lowering healthcare costs, many providers remain reluctant to embrace value-based care (VBC) reimbursement models. Progress toward VBC adoption hasn’t achieved its potential yet, hovering around 60% of all payment models from 2018 to 2021, with the remaining 40% comprised of traditional fee for service (FFS).
Though some providers simply are hesitant to abandon the FFS model that has served them well, others are leery
Read More
TripleBlind Taps Mayo Clinic Platform To De-Identify Patient Data
What You Should Know:
- TripleBlind, an automated, real-time data de-identification company has expanded its relationship with Mayo Clinic Platform.
- For the first time in healthcare, the use of TripleBlind’s Privacy Builder software will enable healthcare systems, via Mayo Clinic Platform, to strategically collaborate on developing the next generation of digital healthcare solutions within secure environments.
Collaboration Details
The collaboration allows the Mayo Clinic Platform
Read More
Healthcare Executives Are Burned Out; Here’s What to Do About It
What You Should Know:
- In the summer of 2022, WittKieffer emailed an online survey to thousands of healthcare C-suite executives of a range of titles at leading hospitals, health systems, academic medical centers, medical groups and other provider organizations. The survey asked questions about feelings of burnout in leaders’ lives and at work as well as the professional impact of the global pandemic.
- A total of 233 healthcare executives, including 63 CEOs, completed the survey. Of
Read More
Anumana & Pfizer Partner on Amyloidosis AI-ECG Algorithm Development
What You Should Know:
- Anumana, an AI-driven health technology company and portfolio company of nference, today announced a multi-year agreement with Pfizer for Anumana to develop an investigational artificial intelligence electrocardiogram algorithm (AI-ECG) designed to enable the early identification of patients who may be at risk of cardiac amyloidosis.
- Anumana will conduct a clinical validation trial and pursue De Novo classification for the algorithm as a
Read More
Clinical Trials: 5 Steps to Greater eConsent Adoption
Clinical trials advance much-needed treatments while offering hope to patients and their families. However, the process of enrolling in a study where they will receive investigational medicines, vaccines or procedures can be a source of friction – enough for patients to rethink participation.
The weight of the decision combined with a perceived lack of transparency of information can confuse or dismay even those patients that are most savvy in the medical industry. Even if they do end
Read More
Research Shows Power of Anumana AI-ECG Algorithms to Detect Heart Conditions
What You Should Know:
- The research is mounting to show that Anumana’s AI-ECG algorithms could dramatically improve screening for cardiovascular disease (CVD), providing early warnings of disease from just a standard electrocardiogram (ECG). Yesterday, a study was published in Nature Medicine that shows an Anumana AI algorithm applied to Apple Watch ECG recordings successfully identified a weak heart pump in patients.
- This follows other recent research findings, published in The
Read More
